Artificial Intelligence: What is the impact on the pharmaceutical industry?

Be prepared! AI is about to transform our daily lives in ways we cannot yet imagine. Over the next few years, AI will drastically impact how we live, work and interact.

 Here are a few sectors that come to mind:

  • Work: AI will both create and replace jobs. Routine and repetitive tasks are likely to be automated, potentially leading to the disappearance of certain jobs. On the other hand, new jobs will emerge to develop, manage, and maintain AI processes.
  • Health: AI is expected to transform healthcare by improving diagnostics, personalizing treatments, and streamlining administrative processes. AI can help doctors to know their patients better.
  • Transport: AI will play a major role in the development of autonomous vehicles, route optimization, and warehouse automation. This will enhance safety, reduce costs, and increase sustainability in the logistics sector.
  • Society: The integration of AI also raises ethical and societal questions, such as privacy, bias in algorithms and the concentration of power. It is crucial to address these issues to ensure AI is used responsibly and fairly.

But what about the pharmaceutical industry? AI and advanced analytics are key business drivers. AI will help create an analytics roadmap to prioritize and align organizational goals. Implementing big-data-based platforms, skill-based training, and changes in processes and organizational design can help businesses operate smarter and with greater confidence. Therefore, the integration of AI can lead to many impactful changes, such as:

  • Research & Development: AI can significantly accelerate drug discovery and research by analyzing large datasets and identifying patterns that human researchers might miss. This has the potential to substantially reduce the time and cost required for new drug development. By analyzing individual patient data, such as genetic information and lifestyle, AI can tailor treatments for each patient.
  • Clinical Trials: Optimizing clinical trials by identifying suitable participants, monitoring patient data in real-time, and predicting potential side effects can lead to faster and more reliable results.
  • Manufacturing: Similar to other industries, AI can improve automation, increase productivity and lower costs. Enhancing predictive maintenance, quality control, and inventory management can lead to higher product quality and less waste.
  • Approval & Compliance: AI can support the preparation of regulatory documentation and help check compliance with legal and regulatory requirements, provided the output is verified by qualified people and the AI system itself is validated.
  • Supply Chain: AI can transform pharmaceutical logistics by enhancing supply chain visibility, predicting disruptions, and optimizing inventory management. This can reduce waste, ensure timely deliveries, and improve the overall efficiency of the supply chain.
  • Governance & Validation: In a GxP environment, AI systems must be validated, their outputs reviewed by qualified staff, and patient data protected. Regulators are working on dedicated expectations, such as the draft EU GMP Annex 22 on AI (still under revision) and the EU AI Act.

In Conclusion

AI is already changing how pharmaceutical companies research, manufacture and deliver medicines. The potential is real, but in a GxP environment the value only materializes when AI is introduced in a controlled way: validated, supervised by qualified people, with patient data protected and safeguarded by ethical standards.

Three steps help companies get started:

  • Map your use cases: Identify where AI could add value, from documentation support to predictive maintenance, and prioritize by risk and benefit.
  • Validate on a risk basis: Treat AI systems like any other GxP system, with clear intended use, documented performance and human review of the output. Regulators are working on dedicated expectations, such as the draft EU GMP Annex 22.
  • Invest in people: Train teams to work with AI and to question its results, so that it supports their judgement rather than replaces it.

Companies that get this balance right will benefit first. Would you like to discuss where AI fits in your organization? Contact Farma Consulting & Partners.

Op zoek naar een QA consultant?

Contacteer ons